65 results
Page 2 of 4
8-K
EX-99.1
952i 8f8y
18 Mar 21
Regulation FD Disclosure
8:00am
8-K
EX-1.1
3jq1g19vhslc
22 Jun 20
Entry into a Material Definitive Agreement
5:26pm
424B5
ifchew
22 Jun 20
Prospectus supplement for primary offering
5:22pm
S-3ASR
2wfd2
22 Jun 20
Automatic shelf registration
4:52pm
8-K
EX-99
agh6k1ly
5 Jun 20
Regulation FD Disclosure
4:05pm
8-K
EX-99
i22pzy64
19 May 20
Cue Biopharma Reports First Quarter 2020 Results, Updates ofCUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
4:06pm
8-K
EX-1.1
nlwqlezo 8ramzlib
27 Mar 20
Entry into a Material Definitive Agreement
4:53pm
424B5
gzmbxh9qnwvhat7w
27 Mar 20
Prospectus supplement for primary offering
4:50pm
8-K
EX-99
kqiuy9aa
17 Mar 20
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:23pm
8-K
EX-99
j3h9 j3nmp0tsh3nyi
2 Mar 20
Regulation FD Disclosure
4:22pm
8-K
EX-1.1
52tx2xbv
26 Nov 19
Entry into a Material Definitive Agreement
12:00am
424B5
6wmm2eg2rni
25 Nov 19
Prospectus supplement for primary offering
5:28pm